{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:09:37Z","timestamp":1777396177375,"version":"3.51.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.autrev.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T16:05:48Z","timestamp":1487001948000},"page":"335-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Autoimmune neuropathies associated to rheumatic diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"Alberto R.M.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamarli","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Marcondes C.","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.02.003_bb0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.62.4.310","article-title":"Epidemiology of peripheral neuropathy","volume":"62","author":"Martyn","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0010","first-page":"11","article-title":"An approach to patients with peripheral neuropathy","volume":"9","author":"Shy","year":"2003","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jnnp.11.2.73","article-title":"Primary sensory neuropathy with muscular changes associated with carcinoma","volume":"11","author":"Denny-Brown","year":"1948","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0020","first-page":"873587","article-title":"Sensory neuronopathy and autoimmune diseases","volume":"2012","author":"Martinez","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2017.02.003_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1474-4422(05)70096-X","article-title":"Sensory neuron diseases","volume":"4","author":"Sghirlanzoni","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0030","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1468-1331.2008.02332.x","article-title":"Chronic acquired sensory neuron diseases","volume":"15","author":"Damasceno","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mus.20100","article-title":"Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies)","volume":"30","author":"Kuntzer","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-2008-1041406","article-title":"Sensory neuronopathy","volume":"7","author":"Asbury","year":"1987","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0050","first-page":"708","article-title":"Sensory neuronopathy and pure sensory neuropathy","volume":"3","author":"Asbury","year":"1990","journal-title":"Curr Opin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2017.02.003_bb0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awp136","article-title":"The pattern and diagnostic criteria of sensory neuronopathy: a case-control study","volume":"132","author":"Camdessanch\u00e9","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.02.003_bb0060","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/jnnp-2014-309730","article-title":"Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy","volume":"86","author":"Antoine","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.surneu.2007.01.057","article-title":"Dorsal root ganglionectomy for the diagnosis of sensory neuropathies. Surgical technique and results","volume":"69","author":"Colli","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.02.003_bb0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.2010.222109","article-title":"Peripheral neuropathies in Sj\u00f6gren syndrome: a new reappraisal","volume":"82","author":"Pavlakis","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/NRL.0b013e3181ebe59f","article-title":"Peripheral nervous system manifestations of Sj\u00f6gren syndrome. Clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies","volume":"16","author":"Birnbaum","year":"2010","journal-title":"Neurologist"},{"key":"10.1016\/j.autrev.2017.02.003_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.berh.2012.01.012","article-title":"Sj\u00f6gren's syndrome, the old and the new","volume":"26","author":"Peri","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0090","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.02.003_bb0095","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp.57.8.983","article-title":"Peripheral neuropathy associated with primary Sjogren's syndrome","volume":"57","author":"Gemignani","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0100","doi-asserted-by":"crossref","unstructured":"Font J, Valls J, Cervera R, Pou A, Ingelmo M, Graus F. Pure sensory neuropathy in patients with primary Sjogren's syndrome: clinical, immunological, and electromyographic findings. Annals of the Rheumatic Diseases1990;49:775\u20138.","DOI":"10.1136\/ard.49.10.775"},{"key":"10.1016\/j.autrev.2017.02.003_bb0105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2169\/internalmedicine.36.690","article-title":"Manifestations of primary Sjogren's syndrome in Japanese patients","volume":"36","author":"Tajima","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2017.02.003_bb0110","first-page":"862","article-title":"Acute sensory neuronopathy as the presenting symptom of Sjogren's syndrome","volume":"13","author":"Souayah","year":"2006","journal-title":"Case Rep \/ J Clin Neurosci"},{"key":"10.1016\/j.autrev.2017.02.003_bb0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejim.2013.10.005","article-title":"Immunological profiles determine neurological involvement in Sj\u00f6gren's syndrome","volume":"25","author":"Jamilloux","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2017.02.003_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaut.2012.01.003","article-title":"Peripheral neuropathies in Sj\u00f6gren's syndrome: a critical update on clinical features and pathogenetic mechanisms","volume":"39","author":"Pavlakis","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.02.003_bb0125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1212\/WNL.48.4.855","article-title":"Peripheral neuropathy associated with sicca complex","volume":"48","author":"Grant","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.02.003_bb0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10067-010-1458-7","article-title":"Clinical manifestations of neurological involvement in primary Sj\u00f6gren's syndrome","volume":"30","author":"Gono","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2013-000651","article-title":"The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis","volume":"14","author":"Berkowitz","year":"2014","journal-title":"Pract Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0140","first-page":"29","article-title":"Neurological involvement in primary Sj\u00f6gren syndrome","volume":"38","author":"Teixeira","year":"2013","journal-title":"Acta Reumatol Port"},{"issue":"5","key":"10.1016\/j.autrev.2017.02.003_bb0145","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s004150050106","article-title":"Early asymmetric neuropathy in primary Sj\u00f6gren's syndrome","volume":"244","author":"Denislic","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0165","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jon.12210","article-title":"Neuroimaging in sensory neuronopathy","volume":"25","author":"Casseb","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.autrev.2017.02.003_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0022-510X(95)00134-N","article-title":"Anti-dorsal root ganglion neuron antibody in a case of dorsal root ganglionitis associated with Sj\u00f6gren's syndrome","volume":"132","author":"Satake","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2017.02.003_bb0175","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awh662","article-title":"The clinical heterogeneity of immune sensory and autonomic neuropathies with (or without) sicca","volume":"128","author":"Dyck","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.02.003_bb0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jnnp.60.6.699","article-title":"Intravenous immunoglobulin therapy in sensory neuropathy associated with Sj\u00f6gren's syndrome","volume":"60","author":"Molina","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/01.WNL.0000046680.47883.7D","article-title":"Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sj\u00f6gren's syndrome","volume":"60","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.02.003_bb0190","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/acr.20495","article-title":"Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sj\u00f6gren's syndrome: a national multicentric retrospective study","volume":"63","author":"Rist","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0195","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000052142","article-title":"Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sj\u00f6gren's syndrome","volume":"45","author":"Chen","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clineuro.2004.10.001","article-title":"Pulse-cyclophosphamide in the treatment of ataxic sensory and cranial nerve neuropathy associated with Sjogren's syndrome","volume":"107","author":"Kastrup","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2017.02.003_bb0205","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1212\/WNL.51.5.1451","article-title":"D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjogren's syndrome","volume":"51","author":"Asahina","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.02.003_bb0210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20664","article-title":"Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial","volume":"35","author":"Gorson","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0215","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.59.7.1113","article-title":"Severe sensory neuronopathy responsive to infliximab in primary Sjogren's syndrome","volume":"59","author":"Caroyer","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.02.003_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003632","article-title":"Sj\u00f6gren sensory neuronopathy (Sj\u00f6gren ganglionopathy): long-term outcome and treatment response in a series of 13 cases","volume":"95","author":"Pereira","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0225","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0961203311434105","article-title":"Ataxic sensory neuronopathy in a patient with systemic lupus erythematosus","volume":"21","author":"Wang","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.02.003_bb0230","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","article-title":"Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients","volume":"38","author":"Pu\u00e9chal","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/1673-5374.150716","article-title":"Nerve biopsy findings contribute to diagnosis of multiple mononeuropathy: 78% of findings support clinical diagnosis","volume":"10","author":"Zhang","year":"2015","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.autrev.2017.02.003_bb0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ncl.2013.01.007","article-title":"The neuropathies of vasculitis","volume":"31","author":"Collins","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2017.02.003_bb0245","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0034-1390390","article-title":"Peripheral neuropathies of rheumatologic disease and gluten-related disorders","volume":"34","author":"Reda","year":"2014","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0250","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0733-8619(05)70350-9","article-title":"Necrotizing peripheral nerve vasculitis","volume":"15","author":"Said","year":"1997","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2017.02.003_bb0255","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/124.6.1197","article-title":"Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety","volume":"124","author":"Dyck","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.02.003_bb0260","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jnen\/59.6.525","article-title":"Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN)","volume":"59","author":"Dyck","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0265","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mus.880130703","article-title":"Invited review: peripheral neuropathy in Sjogren's syndrome","volume":"13","author":"Kaplan","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0270","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1097-4598(200102)24:2<154::AID-MUS20>3.0.CO;2-3","article-title":"Neuromuscular complications of connective tissue diseases","volume":"24","author":"Rosenbaum","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0275","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ncl.2011.12.013","article-title":"Electrodiagnosis of peripheral neuropathy","volume":"30","author":"Ross","year":"2012","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2017.02.003_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nic.2013.03.023","article-title":"Peripheral neuropathy: clinical and electrophysiological considerations","volume":"24","author":"Chung","year":"2014","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.autrev.2017.02.003_bb0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ncl.2013.01.004","article-title":"Laboratory evaluation of peripheral neuropathy","volume":"31","author":"Levine","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2017.02.003_bb0290","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/(SICI)1097-4598(199808)21:8<1084::AID-MUS17>3.0.CO;2-U","article-title":"Conduction block in vasculitic neuropathy","volume":"21","author":"Mohamed","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.autrev.2013.10.001","article-title":"Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors","volume":"13","author":"Samson","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.02.003_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vas- culitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","article-title":"Vasculitic neuropathies","volume":"13","author":"Gwathmey","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0310","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00415-012-6760-7","article-title":"Peripheral neuropathy as initial manifestation of primary systemic vasculitides","volume":"260","author":"Wolf","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0315","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp.2006.111013","article-title":"Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis","volume":"78","author":"Cattaneo","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0320","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2017.02.003_bb0325","first-page":"401","article-title":"Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis","volume":"90","author":"Adu","year":"1997","journal-title":"Q JM"},{"key":"10.1016\/j.autrev.2017.02.003_bb0330","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2003-41133","article-title":"Therapy of neurological disorders in systemic vasculitis","volume":"23","author":"Gold","year":"2003","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0335","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semarthrit.2015.02.005","article-title":"Rituximab for remission induction in elderly patients with ANCA-associated vasculitis","volume":"45","author":"Timlin","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0345","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10067-014-2816-7","article-title":"Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters","volume":"34","author":"Chocova","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0350","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/rheumatology\/keu429","article-title":"Indications for IVIG in rheumatic diseases","volume":"54","author":"Mulhearn","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0355","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/art.39104","article-title":"Outcomes of non-severe relapses in ANCA-associated vasculitis treated with glucocorticoids","volume":"67","author":"Miloslavsky","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0360","first-page":"1408","article-title":"Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis","volume":"29","author":"Hattori","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.02.003_bb0370","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.autrev.2010.07.009","article-title":"Microscopic polyangiitis: clinical presentation","volume":"9","author":"Villiger","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.02.003_bb0375","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2014.09.003","article-title":"Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment","volume":"41","author":"Lally","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.autrev.2017.02.003_bb0385","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2014.12.004","article-title":"Churg-Strauss syndrome","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.02.003_bb0390","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0395","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0400","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/rheumatology\/ken175","article-title":"Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production","volume":"47","author":"Pepper","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0405","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0410","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clineuro.2009.07.004","article-title":"Clinical characterization and successful treatment of 6 patients with Churg-Strauss syndrome-associated neuropathy","volume":"111","author":"Nakamura","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2017.02.003_bb0415","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/rcr2.56","article-title":"Marked improvement of Churg-Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide","volume":"2","author":"Umeda","year":"2014","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.autrev.2017.02.003_bb0420","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00415-014-7618-y","article-title":"Research group for IVIg for EGPA\/CSS in Japan. Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial","volume":"262","author":"Koike","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0425","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archneur.58.8.1215","article-title":"Standardized neurologic evaluations of 128 patients with Wegener granulomatosis","volume":"58","author":"de Groot","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0430","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp.2006.111013","article-title":"Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis","volume":"78","author":"Cattaneo","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0435","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/BOR.0b013e32834115f9","article-title":"Neurological involvement in Wegener's granulomatosis","volume":"23","author":"Holle","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0440","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.27240","article-title":"Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group database","volume":"62","author":"Pagnoux","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0445","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0450","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","article-title":"Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients","volume":"84","author":"Guillevin","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.02.003_bb0455","first-page":"221","article-title":"Vasculitis associated with connective tissue diseases","volume":"150","author":"Cozzani","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0460","first-page":"601","article-title":"Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure","volume":"14","author":"Lori","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0465","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.02.003_bb0470","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0475","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ene.12190","article-title":"Epidemiology of chronic inflammatory neuropathies in southeast England","volume":"21","author":"Mahdi-Rogers","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0480","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/brain\/81.2.157","article-title":"Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone","volume":"81","author":"Austin","year":"1958","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.02.003_bb0485","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0490","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.02.003_bb0495","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrrheum.2012.138","article-title":"Peripheral neuropathies in rheumatic disease-a guide to diagnosis","volume":"8","author":"Vallat","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0500","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/practneurol-2014-000831","article-title":"CIDP: mimics and chameleons","volume":"14","author":"Neligan","year":"2014","journal-title":"Pract Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0505","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"12","author":"Eftimov","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2017.02.003_bb0510","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1085-9489.2006.00059.x","volume":"11","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2017.02.003_bb0515","first-page":"249","article-title":"Diagnosis and treatment in inflammatory neuropathies","volume":"80","author":"Lunn","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6 suppl 5","key":"10.1016\/j.autrev.2017.02.003_bb0520","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.51.6_Suppl_5.S16","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin","volume":"51","author":"Hahn","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.autrev.2017.02.003_bb0525","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(12)70093-5","article-title":"IMC Trial Group. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized controlled trial","volume":"11","author":"Nobile-Orazio","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0530","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jns5.12053","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go","volume":"19","author":"Nobile-Orazio","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2017.02.003_bb0535","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0032-1329194","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside","volume":"32","author":"Peltier","year":"2012","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0540","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome","volume":"35","author":"Vina","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0545","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/0961203312440346","article-title":"Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupuserythematosus (SLE) with oral cyclophosphamide","volume":"21","author":"Jasmin","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.02.003_bb0550","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-009-1008-2","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus","volume":"30","author":"Zoilo","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.02.003_bb0555","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1007\/s00296-011-2130-5","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment","volume":"32","author":"Sanz","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.02.003_bb0560","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0565","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cyto.2008.11.002","article-title":"Inflammatory demyelinating events following treatment with anti-tumor necrosis factor","volume":"45","author":"Fromont","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2017.02.003_bb0570","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0575","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mus.21051","article-title":"Lewis\u2013Sumner syndrome associated with infliximab therapy in rheumatoid arthritis","volume":"38","author":"Hooper","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0580","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0585","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain\u2013Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.003_bb0590","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrneurol.2014.117","article-title":"Diagnosis and treatment of chronic acquired demyelinating polyneuropathies","volume":"10","author":"Latov","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2017.02.003_bb0595","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/mus.21274","article-title":"Subacute inflammatory polyradiculopathy associated with Sj\u00f6gren's syndrome","volume":"39","author":"Rigamonti","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0600","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/mus.23339","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sj\u00f6gren syndrome","volume":"45","author":"Sanvito","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.02.003_bb0605","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2169\/internalmedicine.41.142","article-title":"Motor dominant neuropathy in Sjogren's syndrome: report of two cases","volume":"41","author":"Mochizuki","year":"2002","journal-title":"Intern Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217300435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217300435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T10:41:44Z","timestamp":1657795304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217300435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1568997217300435"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.02.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune neuropathies associated to rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}